Pneumococcal conjugate vaccines for adults: reasons for optimism and for caution.
Department of Epidemiology of Microbial Diseases; Yale School of Public Health; New Haven, CT USA.
Daniel M
DM
Weinberger
Department of Epidemiology of Microbial Diseases; Yale School of Public Health; New Haven, CT USA; Department of Pediatrics; Yale University School of Medicine and Department of Investigative Medicine; Yale Graduate School of Arts and Sciences; New Haven, CT USA.
Eugene D
ED
Shapiro
D000328:Adult; D000818:Animals; D006801:Humans; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000276:immunology*; D011018:Pneumonia, Pneumococcal / Q000276:immunology* / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D018074:Vaccines, Conjugate / Q000008:administration & dosage / Q000276:immunology*
C538862:13-valent pneumococcal vaccine; D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate
conjugate vaccines; pneumococcus; pneumonia; prevention; vaccines